Amy Clifton’s 30-Year Journey to Type 1 Narcolepsy Diagnosis Ends in New Hope
Amy Clifton, a mother of three, suffered for nearly three decades with undiagnosed type 1 narcolepsy, a condition caused by a lack of the brain chemical orexin. Her symptoms, including severe daytime sleepiness, hallucinations, and cataplexy (sudden muscle weakness), were repeatedly misdiagnosed as bipolar disorder, hormonal issues, or laziness. The misdiagnoses led to inappropriate treatments and deep despair, including suicidal thoughts and hospitalization at age 29. At age 30, a specialist finally identified her condition. Although insurance initially denied coverage for the expensive medication sodium oxybate due to inconclusive test results, Clifton is now receiving the drug through a patient assistance program. She reports improved energy and fewer hallucinations, though she faces the ongoing challenge of managing a chronic, incurable condition. Clifton is now an advocate for faster diagnosis and better treatment access.
